首页> 外文期刊>Journal of Enam Medical College >Helicobacter Pylori Eradication Therapy in both Erosive and Non-erosive Gastritis — A Prospective Study
【24h】

Helicobacter Pylori Eradication Therapy in both Erosive and Non-erosive Gastritis — A Prospective Study

机译:幽门螺杆菌根除治疗在侵蚀性和非侵蚀性胃炎中的前瞻性研究

获取原文
       

摘要

Background: Infection with Helicobacter pylori (H. pylori) is a recognized cause of peptic ulcer and gastritis. Persistence of infection is a definite risk factor for gastric malignancy. Healing of gastritis after eradication of H. pylori reduces the risks of peptic ulcer disease and gastric malignancy. Objectives: To find out the relationship of H. pylori with erosive and nonerosive gastritis, the effect of anti-H. pylori therapy and to compare the effects of anti-H. pylori therapy between two types of gastritis. Materials and Methods: This prospective study was done in the Gastroenterology department of Bangabandhu Sheikh Mujib Medical University, Dhaka from June 2008 to May 2009. One hundred eighty dyspeptic patients were enrolled for the study. Patients with gastritis diagnosed by endoscopy underwent rapid urease test (RUT). RUT positive patients were considered to have H. pylori infection and were treated with triple therapy (omeprazole, amoxycillin and metronidiazole) for 14 days. Treatment responses were assessed by clinical history and also by endoscopic biopsy and RUT. Results of endoscopic findings and RUT after treatment were compared with pretreatment status. Results: Seventy patients completed the treatment and finally could be assessed. Endoscopic findings of 70 patients revealed that 56 (80%) patients had erosive gastritis and 14 (20%) patients had nonerosive gastritis. After treatment, 47 (67.1%) lesions became normal, 16 (22.9%) remained erosive and 7 (10%) non-erosive as before. Out of 14 non-erosive diseases, 7 became normal, while out of 56 erosive diseases 40 became normal. The erosive group responded significantly better than the non-erosive group (c2=32.766, p<0.001). Fifty nine (84.3%) patients with gastritis showed negative urease test after treatment. Conclusion: Strong relation between H. pylori infection and gastritis was found. Majority were antral erosive gastritis. Erosive group responded better than non-erosive group. DOI: http://dx.doi.org/10.3329/jemc.v4i1.18063 J Enam Med Col 2014; 4(1): 15-20
机译:背景:幽门螺杆菌(幽门螺杆菌)感染是引起消化性溃疡和胃炎的公认原因。感染的持续存在是胃恶性肿瘤的绝对危险因素。根除幽门螺杆菌后治愈胃炎可降低消化性溃疡和胃恶性肿瘤的风险。目的:探讨幽门螺杆菌与糜烂性胃炎和非糜烂性胃炎的关系,以及抗H的作用。幽门螺杆菌疗法并比较抗H的效果。两种胃炎之间的幽门螺杆菌疗法。材料和方法:这项前瞻性研究于2008年6月至2009年5月在达卡的Bangabandhu Sheikh Mujib医科大学的消化内科进行。招募了180名消化不良的患者。通过内窥镜检查诊断为胃炎的患者接受快速尿素酶检测(RUT)。 RUT阳性患者被认为患有幽门螺杆菌感染,并接受三联疗法(奥美拉唑,阿莫西林和甲硝唑)治疗14天。通过临床病史以及内窥镜活检和RUT评估治疗反应。将治疗后的内窥镜检查结果和RUT结果与治疗前的状态进行比较。结果:70名患者完成了治疗,最后可以进行评估。内镜检查发现70例患者中有56例(80%)有糜烂性胃炎,而14例(20%)有非糜烂性胃炎。治疗后,与以前一样,有47处(67.1%)病变恢复正常,有16处(22.9%)保持糜烂,而7处(10%)无糜烂。在14种非侵蚀性疾病中,有7种恢复了正常,而在56种侵蚀性疾病中,有40种恢复了正常。侵蚀性组的反应明显优于非侵蚀性组(c2 = 32.766,p <0.001)。治疗后有59名(84.3%)胃炎患者尿素酶测试阴性。结论:发现幽门螺杆菌感染与胃炎之间存在密切关系。多数为窦性糜烂性胃炎。侵蚀性组的反应优于非侵蚀性组。 DOI:http://dx.doi.org/10.3329/jemc.v4i1.18063 J Enam Med Col 2014; 4(1):15-20

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号